Article -> Article Details
| Title | Women’s Health Diagnostics Market Size, Share, Trends, Growth and Outlook Report 2025-2033 |
|---|---|
| Category | Fitness Health --> Health Articles |
| Meta Keywords | Women'S Health Diagnostics Market |
| Owner | akshaykumar |
| Description | |
| Market Overview The global Women's Health Diagnostics Market size reached USD 31.1 Billion in 2024. It is expected to grow to USD 54.2 Billion by 2033, exhibiting a CAGR of 6.4% during 2025-2033. The market growth is driven by increasing cases of chronic and lifestyle-related diseases, technological advancements in diagnostics, growing awareness through campaigns, acceptance of point-of-care diagnostics, and telemedicine expansion. Study Assumption Years
Women's Health Diagnostics Market Key Takeaways
Sample Request Link: https://www.imarcgroup.com/womens-health-diagnostics-market/requestsample Market Growth Factors The womens health diagnostics market is expected to grow because the prevalence of chronic and lifestyle diseases in the female population increases for cervical cancer, osteoporosis, cardiovascular diseases, breast cancer etc. According to the data that the WHO reports, approximately 2.3 million females got diagnoses of breast cancer diseases in 2022 and 670000 deaths got reported. Physical inactivity grows and diets become unhealthy, which leads to obesity, diabetes and other lifestyle related diseases in women, driving the market. Government initiates programs to make people more aware of women's chronic diseases and projects an increase in the market's growth. For instance, the American Cancer Society and Imperial Chemical Industries (currently a part of AstraZeneca) initiated Breast Cancer Awareness Month in 1985 for promotion of awareness about breast cancer and to raise funds for research and treatment. These initiatives also focus upon detecting early and screening health regularly, thus penetrating the diagnostics market. Furthermore, acceptance and advancements in point-of-care diagnostics is also expected to fuel the growth of the market, as point-of-care diagnostics can be performed near a patient and provide instant results to make the required decisions. These advantages are valuable in areas such as pregnancy complications, cancer screening and sexually transmitted diseases, among others. The global point-of-care diagnostics market reached USD 49.2 Billion in value in 2023 and should grow 7.9% each year from 2024 to 2032. Market Segmentation Breakup by Type:
Breakup by Application:
Breakup by End User:
Regional Insights North America dominates the women's health diagnostics market, attributed to its robust healthcare infrastructure, presence of key industry players, and increased healthcare expenditure. In 2022, US health spending rose by 4.1% to USD 4.4 trillion, or USD 13,493 per capita, indicating substantial investment in healthcare. The region's strong focus on early diagnosis, preventive care, and R&D investment accelerates market growth. Recent Developments & News In March 2023, Visby Medical received U.S. FDA approval for its sexual health test, a second-generation PCR kit utilizing self-collected vaginal swabs to detect STIs such as trichomoniasis, gonorrhea, and chlamydia. In the same month, F. Hoffmann-La Roche Ltd announced a partnership with Eli Lilly and Company to develop the Elecsys Amylois Plasma Panel (EAPP), a novel blood test supporting original Alzheimer's disease diagnosis. In April 2023, Quest Diagnostics completed acquisition of selected laboratory assets from NewYork-Presbyterian, aiming to provide quality, cost-effective testing through combined strengths. Key Players
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization. Request For Customization: https://www.imarcgroup.com/request?type=report&id=4956&flag=E About Us IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research. Contact Us IMARC Group, 134 N 4th St. Brooklyn, NY 11249, USA, Email: sales@imarcgroup.com, Tel No: (D) +91 120 433 0800, United States: +1-201971-6302 | |